𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial

✍ Scribed by Ostri, P. ;Swartz, R. ;Meyhoff, H.-H. ;Petersen, J.H. ;Lindg�rd, G. ;Frimodt-M�ller, C. ;Andersson, T. ;Nielsen, M.S.

Publisher
Springer
Year
1989
Tongue
English
Weight
401 KB
Volume
17
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Symptomatic treatment of benign prostati
Symptomatic treatment of benign prostatic obstruction with Nicergoline: A placebo controlled clinical study and urodynamic evaluation
✍ Ronchi, F. ;Margonato, A. ;Ceccardi, R. ;Rigatti, P. ;Rossini, B.M. 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 321 KB

A double-blind crossover study of the alpha-blocker Nicergoline was carried out in sixteen patients affected by benign prostatic bladder outflow obstruction. The "irritative" symptoms of prostatic hypertrophy, including nocturnal frequency and dysuria, were improved after Nicergoline significantly m

Estrogen reduction by aromatase inhibiti
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane
✍ Radlmaier, Albert; Eickenberg, Hans U.; Fletcher, Matthew S.; Fourcade, Richard 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

## BACKGROUND. The concept of estrogen withdrawal by an aromatase inhibitor in the treatment of benign prostatic hyperplasia (BPH) was assessed in a prospective, randomized, double-blind, placebo-controlled multicenter trial. METHODS. Two hundred and ninety-two patients with clinical symptoms of B